537 related articles for article (PubMed ID: 32069106)
1. Prognostic Effects of Treatment Strategies for Left Main Versus Non-Left Main Bifurcation Percutaneous Coronary Intervention With Current-Generation Drug-Eluting Stent.
Choi KH; Song YB; Lee JM; Park TK; Yang JH; Hahn JY; Choi JH; Choi SH; Kim HS; Chun WJ; Hur SH; Han SH; Rha SW; Chae IH; Jeong JO; Heo JH; Yoon J; Lim DS; Park JS; Hong MK; Doh JH; Cha KS; Kim DI; Lee SY; Chang K; Hwang BH; Choi SY; Jeong MH; Hong SJ; Nam CW; Koo BK; Gwon HC
Circ Cardiovasc Interv; 2020 Feb; 13(2):e008543. PubMed ID: 32069106
[TBL] [Abstract][Full Text] [Related]
2. Differential prognostic impact of treatment strategy among patients with left main versus non-left main bifurcation lesions undergoing percutaneous coronary intervention: results from the COBIS (Coronary Bifurcation Stenting) Registry II.
Song YB; Hahn JY; Yang JH; Choi SH; Choi JH; Lee SH; Jeong MH; Kim HS; Lee JH; Yu CW; Rha SW; Jang Y; Yoon JH; Tahk SJ; Seung KB; Oh JH; Park JS; Gwon HC
JACC Cardiovasc Interv; 2014 Mar; 7(3):255-63. PubMed ID: 24529936
[TBL] [Abstract][Full Text] [Related]
3. Dual Antiplatelet Therapy Duration Determines Outcome After 2- But Not 1-Stent Strategy in Left Main Bifurcation Percutaneous Coronary Intervention.
Rhee TM; Park KW; Kim CH; Kang J; Han JK; Yang HM; Kang HJ; Koo BK; Kim HS
JACC Cardiovasc Interv; 2018 Dec; 11(24):2453-2463. PubMed ID: 30573055
[TBL] [Abstract][Full Text] [Related]
4. Benefit of Prolonged Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stent for Coronary Bifurcation Lesions: Results From the Coronary Bifurcation Stenting Registry II.
Jang WJ; Ahn SG; Song YB; Choi SH; Chun WJ; Oh JH; Cho SW; Kim BS; Yoon JH; Koo BK; Yu CW; Jang YS; Tahk SJ; Kim HS; Gwon HC; Lee SY; Hahn JY
Circ Cardiovasc Interv; 2018 Jul; 11(7):e005849. PubMed ID: 30006330
[TBL] [Abstract][Full Text] [Related]
5. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
[TBL] [Abstract][Full Text] [Related]
6. Major Predictors of Long-Term Clinical Outcomes After Percutaneous Coronary Intervention for Coronary Bifurcation Lesions With 2-Stent Strategy: Patient-Level Analysis of the Korean Bifurcation Pooled Cohorts.
Song PS; Song YB; Lee JM; Hahn JY; Choi SH; Choi JH; Lee SH; Park KW; Kim HS; Jang Y; Seung KB; Oh JH; Gwon HC
JACC Cardiovasc Interv; 2016 Sep; 9(18):1879-86. PubMed ID: 27592016
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Effect of Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the BIOSCIENCE Randomized Trial.
Iglesias JF; Heg D; Roffi M; Tüller D; Noble S; Muller O; Moarof I; Cook S; Weilenmann D; Kaiser C; Cuculi F; Häner J; Jüni P; Windecker S; Pilgrim T
Circ Cardiovasc Interv; 2019 Aug; 12(8):e008024. PubMed ID: 31525083
[TBL] [Abstract][Full Text] [Related]
8. Randomized All-Comers Evaluation of a Permanent Polymer Zotarolimus-Eluting Stent Versus a Polymer-Free Amphilimus-Eluting Stent.
Rozemeijer R; Stein M; Voskuil M; van den Bor R; Frambach P; Pereira B; Koudstaal S; Leenders GE; Timmers L; Rittersma SZ; Kraaijeveld AO; Agostoni P; Roes KC; Doevendans PA; Stella PR;
Circulation; 2019 Jan; 139(1):67-77. PubMed ID: 30586704
[TBL] [Abstract][Full Text] [Related]
9. Outcomes Among Patients Undergoing Distal Left Main Percutaneous Coronary Intervention.
Kandzari DE; Gershlick AH; Serruys PW; Leon MB; Morice MC; Simonton CA; Lembo NJ; Banning AP; Merkely B; van Boven AJ; Ungi I; Kappetein AP; Sabik JF; Généreux P; Dressler O; Stone GW
Circ Cardiovasc Interv; 2018 Oct; 11(10):e007007. PubMed ID: 30354633
[TBL] [Abstract][Full Text] [Related]
10. Differential Prognostic Effect Between First- and Second-Generation Drug-Eluting Stents in Coronary Bifurcation Lesions: Patient-Level Analysis of the Korean Bifurcation Pooled Cohorts.
Lee JM; Hahn JY; Kang J; Park KW; Chun WJ; Rha SW; Yu CW; Jeong JO; Jeong MH; Yoon JH; Jang Y; Tahk SJ; Gwon HC; Koo BK; Kim HS
JACC Cardiovasc Interv; 2015 Aug; 8(10):1318-1331. PubMed ID: 26315734
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Clinical Outcomes and Optimal Stent Strategy in Left Main Coronary Bifurcation Stenting.
Cho S; Kang TS; Kim JS; Hong SJ; Shin DH; Ahn CM; Kim BK; Ko YG; Choi D; Song YB; Hahn JY; Choi SH; Gwon HC; Hong MK; Jang Y
JACC Cardiovasc Interv; 2018 Jul; 11(13):1247-1258. PubMed ID: 29976361
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Clinical Outcomes After Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary In-Stent Restenosis: A Multicenter Italian Experience.
Moscarella E; Ielasi A; Granata F; Coscarelli S; Stabile E; Latib A; Cortese B; Tespili M; Tanaka A; Capozzolo C; Caliendo L; Colombo A; Varricchio A
Circ Cardiovasc Interv; 2016 Apr; 9(4):e003148. PubMed ID: 27059683
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the planned one- and elective two-stent techniques in patients with coronary bifurcation lesions with or without acute coronary syndrome from the COBIS II Registry.
Kim MC; Ahn Y; Sun Sim D; Joon Hong Y; Han Kim J; Ho Jeong M; Gwon HC; Kim HS; Rha SW; Yoon JH; Jang Y; Tahk SJ; Seung KB
Catheter Cardiovasc Interv; 2018 Nov; 92(6):1050-1060. PubMed ID: 29573537
[TBL] [Abstract][Full Text] [Related]
14. Subgroup Analysis Comparing Ultrathin, Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin, Durable Polymer Everolimus-Eluting Stents in Acute Coronary Syndrome Patients.
Roguin A; Kandzari DE; Marcusohn E; Koolen JJ; Doros G; Massaro JM; Garcia-Garcia HM; Bennett J; Gharib EG; Cutlip DE; Waksman R
Circ Cardiovasc Interv; 2018 Oct; 11(10):e007331. PubMed ID: 30354631
[TBL] [Abstract][Full Text] [Related]
15. Double Kissing Crush Versus Provisional Stenting for Left Main Distal Bifurcation Lesions: DKCRUSH-V Randomized Trial.
Chen SL; Zhang JJ; Han Y; Kan J; Chen L; Qiu C; Jiang T; Tao L; Zeng H; Li L; Xia Y; Gao C; Santoso T; Paiboon C; Wang Y; Kwan TW; Ye F; Tian N; Liu Z; Lin S; Lu C; Wen S; Hong L; Zhang Q; Sheiban I; Xu Y; Wang L; Rab TS; Li Z; Cheng G; Cui L; Leon MB; Stone GW
J Am Coll Cardiol; 2017 Nov; 70(21):2605-2617. PubMed ID: 29096915
[TBL] [Abstract][Full Text] [Related]
16. High-Speed Rotational Atherectomy Versus Modified Balloons Prior to Drug-Eluting Stent Implantation in Severely Calcified Coronary Lesions.
Abdel-Wahab M; Toelg R; Byrne RA; Geist V; El-Mawardy M; Allali A; Rheude T; Robinson DR; Abdelghani M; Sulimov DS; Kastrati A; Richardt G
Circ Cardiovasc Interv; 2018 Oct; 11(10):e007415. PubMed ID: 30354632
[TBL] [Abstract][Full Text] [Related]
17. Unselected Use of Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent for Coronary Revascularization.
Yamaji K; Zanchin T; Zanchin C; Stortecky S; Koskinas KC; Hunziker L; Praz F; Blöchlinger S; Moro C; Moschovitis A; Seiler C; Valgimigli M; Billinger M; Pilgrim T; Heg D; Windecker S; Räber L
Circ Cardiovasc Interv; 2018 Sep; 11(9):e006741. PubMed ID: 30354590
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome after crush versus culotte stenting of coronary artery bifurcation lesions: the Nordic Stent Technique Study 36-month follow-up results.
Kervinen K; Niemelä M; Romppanen H; Erglis A; Kumsars I; Maeng M; Holm NR; Lassen JF; Gunnes P; Stavnes S; Jensen JS; Galløe A; Narbute I; Sondore D; Christiansen EH; Ravkilde J; Steigen TK; Mannsverk J; Thayssen P; Hansen KN; Helqvist S; Vikman S; Wiseth R; Aarøe J; Jokelainen J; Thuesen L;
JACC Cardiovasc Interv; 2013 Nov; 6(11):1160-5. PubMed ID: 24262616
[TBL] [Abstract][Full Text] [Related]
19. Comparison of 5-year outcomes in patients with and without unprotected left main coronary artery disease after treatment with sirolimus-eluting stents: insights from the j-Cypher registry.
Toyofuku M; Kimura T; Morimoto T; Hayashi Y; Shiode N; Nishikawa H; Nakao K; Shirota K; Kawai K; Hiasa Y; Kadota K; Nozaki Y; Isshiki T; Sone T; Mitsudo K;
JACC Cardiovasc Interv; 2013 Jul; 6(7):654-63. PubMed ID: 23866178
[TBL] [Abstract][Full Text] [Related]
20. Impact of the complexity of bifurcation lesions treated with drug-eluting stents: the DEFINITION study (Definitions and impact of complEx biFurcation lesIons on clinical outcomes after percutaNeous coronary IntervenTIOn using drug-eluting steNts).
Chen SL; Sheiban I; Xu B; Jepson N; Paiboon C; Zhang JJ; Ye F; Sansoto T; Kwan TW; Lee M; Han YL; Lv SZ; Wen SY; Zhang Q; Wang HC; Jiang TM; Wang Y; Chen LL; Tian NL; Cao F; Qiu CG; Zhang YJ; Leon MB
JACC Cardiovasc Interv; 2014 Nov; 7(11):1266-76. PubMed ID: 25326748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
